Precision for Medicine opens new Japan office

Gesynta Pharma doses first patient in vipoglanstat Phase 2 clinical proof-of-concept trial

Avene partners with BotDesign to advance clinical studies in dermo-cosmetics

AnaCardio secures US patent for AC01, extending protection until 2042

Dexcom highlights new diabetes outcomes and product roadmap at ATTD 2026

Curatis and Neupharma partner to develop corticorelin for peritumoral brain edema in Japan

Samsung Biologics collaborates with Lilly for new Gateway Labs site in Korea

Citius Oncology reports positive topline results from Phase 1 clinical trial of LYMPHIR combination

CMIC agrees agentic AI partnership with Bluenote

GenomOncology partners with WeTrials to support CNS cancer clinical trials

Target ALS awards two-year research grant to AcuraStem for advancing therapeutics targeting SYF2

Ascletis reports Phase II weight‑loss results for ASC30 depot formulation

NS Pharma and NCNP report 4.5-year brogidirsen data for DMD treatment

Biofrontera reports Phase 2b data for Ameluz photodynamic therapy in acne vulgaris treatment

Koselugo approved in Canada for adults with NF1 and inoperable plexiform neurofibromas